BioPharma Credit PLC (BPCR.L)
USD 0.89
(0.91%)
USD 0.89
(0.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.03 Million USD | 5.33% |
| 2022 | 1.93 Million USD | -35.75% |
| 2021 | 3.01 Million USD | 35.77% |
| 2020 | 2.21 Million USD | 23.79% |
| 2019 | 1.79 Million USD | -79.11% |
| 2018 | 8.57 Million USD | 32.3% |
| 2017 | 6.48 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.6 Million USD | -63.35% |
| 2024 Q2 | 3.6 Million USD | 0.0% |
| 2023 Q4 | 9.84 Million USD | -0.03% |
| 2023 Q1 | 3.79 Million USD | -72.97% |
| 2023 FY | 2.03 Million USD | 5.33% |
| 2023 Q2 | 3.79 Million USD | 0.0% |
| 2023 Q3 | 9.84 Million USD | 159.56% |
| 2022 Q3 | 14.04 Million USD | 261.08% |
| 2022 Q1 | 3.88 Million USD | -30.43% |
| 2022 FY | 1.93 Million USD | -35.75% |
| 2022 Q4 | 14.04 Million USD | 0.0% |
| 2022 Q2 | 3.88 Million USD | 0.0% |
| 2021 Q1 | 3.87 Million USD | -39.98% |
| 2021 Q4 | 5.58 Million USD | 0.0% |
| 2021 Q2 | 3.87 Million USD | 0.0% |
| 2021 Q3 | 5.58 Million USD | 44.38% |
| 2021 FY | 3.01 Million USD | 35.77% |
| 2020 FY | 2.21 Million USD | 23.79% |
| 2020 Q4 | 6.44 Million USD | 0.0% |
| 2020 Q1 | 3.99 Million USD | -63.18% |
| 2020 Q2 | 3.99 Million USD | 0.0% |
| 2020 Q3 | 6.44 Million USD | 61.56% |
| 2019 Q2 | 3.44 Million USD | 0.0% |
| 2019 FY | 1.79 Million USD | -79.11% |
| 2019 Q4 | 10.84 Million USD | 0.0% |
| 2019 Q3 | 10.84 Million USD | 214.7% |
| 2019 Q1 | 3.44 Million USD | -65.83% |
| 2018 FY | 8.57 Million USD | 32.3% |
| 2018 Q3 | 10.08 Million USD | 187.78% |
| 2018 Q2 | 3.5 Million USD | 0.0% |
| 2018 Q1 | 3.5 Million USD | 259.79% |
| 2018 Q4 | 10.08 Million USD | 0.0% |
| 2017 FY | 6.48 Million USD | 0.0% |
| 2017 Q4 | 973.75 Thousand USD | 0.0% |
| 2017 Q2 | 2.55 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ameriprise Financial, Inc. | 15.53 Billion USD | 99.987% |
| Gladstone Investment Corporation | 39.1 Million USD | 94.791% |
| Principal Financial Group, Inc. | 5.07 Billion USD | 99.96% |
| Africa Opportunity Fund Limited | 1.68 Million USD | -20.584% |
| BH Macro Limited | 160.03 Million USD | 98.727% |
| CATCo Reinsurance Opportunities Fund Ltd. | -183.39 Thousand USD | 1210.748% |
| Craven House Capital Plc | 186 Thousand USD | -995.161% |
| JPEL Private Equity Limited | 1.17 Million USD | -73.954% |
| Pershing Square Holdings, Ltd. | 483.23 Million USD | 99.578% |
| Ecofin U.S. Renewables Infrastructure Trust PLC | -5.54 Million USD | 136.742% |
| RTW Venture Fund Limited | 86.29 Million USD | 97.64% |
| Tufton Oceanic Assets Limited | 1.01 Million USD | -100.96% |
| Symphony International Holdings Limited | 114.51 Million USD | 98.221% |
| Tetragon Financial Group Limited | 17.6 Million USD | 88.426% |
| Taylor Maritime Investments Limited | -42.53 Million USD | 104.789% |
| TMT Investments PLC | 1.28 Million USD | -59.127% |
| Third Point Investors Limited | 13.01 Million USD | 84.347% |